What Is a Watershed Stroke and What Causes It?

A stroke occurs when the brain’s blood supply is interrupted, causing brain cells to die from a lack of oxygen and nutrients. The vast majority of these events are ischemic strokes, which result from a blockage in a blood vessel, or hemorrhagic strokes, which involve bleeding into the brain tissue. A less common but distinct type is the watershed stroke, also known as a border-zone infarct, which arises from a different mechanism than a typical blockage. This specific event occurs in areas of the brain that are geographically the most distant from the main arteries supplying blood.

Understanding the Brain’s Vulnerable Border Zones

The brain’s arterial system divides the tissue into several distinct supply territories, each fed by a major artery, such as the anterior, middle, and posterior cerebral arteries (ACA, MCA, and PCA). A watershed area is the tissue that lies at the farthest reach of the capillary beds of two adjacent major arterial territories. These border zones are particularly vulnerable because they receive the least robust blood supply under normal conditions.

When the body experiences a drop in overall blood flow, a state known as hypoperfusion, these distal zones are the first to suffer tissue damage. The injury occurs not because of a localized clot blocking a single vessel, but because the systemic pressure is too low to push enough blood to these far-flung regions of the brain.

Watershed infarcts are topographically categorized into two main types: cortical and internal. Cortical watershed infarcts occur between the superficial branches of the ACA/MCA and the MCA/PCA, affecting the outer layers of the brain. Internal watershed infarcts occur in the deeper white matter between the superficial arteries and the penetrating arteries that supply the deep brain structures. Both types result from the same fundamental issue of inadequate perfusion pressure.

Systemic Events That Trigger Hypoperfusion

The primary cause of a watershed stroke is a sudden and profound drop in systemic blood pressure, which leads to cerebral hypoperfusion. This means the event is often triggered by a major medical crisis affecting the entire body’s circulatory system rather than an issue confined to the brain’s arteries. One of the most common precursors is massive blood loss, or hemorrhage, such as from a severe gastrointestinal bleed or traumatic injury, which drastically reduces the total blood volume and pressure.

Severe systemic shock, whether septic shock from a widespread infection or cardiogenic shock due to a heart attack, can also precipitate a watershed stroke. In these scenarios, the heart is unable to pump blood effectively, or the blood vessels dilate excessively, causing blood pressure to plummet. Even a sudden drop in blood pressure during a major surgical procedure can be enough to cause this specific type of brain injury.

In some cases, a watershed stroke can occur even without a major systemic drop in blood pressure if the person has pre-existing, severe narrowing of a major neck artery, such as the carotid artery. If the carotid artery is significantly stenosed, the brain is already struggling to receive adequate flow, and even a slight, transient dip in blood pressure can tip the balance toward hypoperfusion in the vulnerable border zones.

Identifying the Distinct Neurological Signs

The symptoms of a watershed stroke are often distinct because the affected border zones correspond to specific functional areas of the brain. A common presentation involves weakness that is more pronounced in the proximal limbs, meaning the shoulders and hips, while often sparing the face, hands, and feet. This pattern is sometimes described as a “man-in-the-barrel” syndrome, where the person has difficulty lifting their arms and legs but retains fine motor control in the extremities.

The injury pattern can also lead to specific gait disturbances, characterized by unsteadiness or a staggering walk, as the motor control areas for the lower body are affected. If the infarct occurs in the border zone between the middle and posterior cerebral arteries, patients may experience disturbances in visual processing. These can range from cortical blindness to difficulty recognizing objects or navigating space.

Unlike a stroke caused by a blockage in a single artery, watershed strokes caused by global hypoperfusion often affect both sides of the brain simultaneously or sequentially, leading to bilateral symptoms. Because the underlying problem is a reduction in overall flow, the neurological deficits can sometimes fluctuate or appear milder at first, which can complicate the diagnosis compared to a classic clot-based stroke.

Acute Management and Rehabilitation Pathways

The immediate management of a watershed stroke focuses on reversing the underlying hypoperfusion that caused the injury. Medical teams must quickly identify and correct the systemic cause, whether that means stopping a hemorrhage, treating a severe infection, or addressing a cardiac issue that caused the drop in blood pressure. The priority is to restore adequate blood pressure to ensure the brain receives sufficient oxygenated blood.

In certain situations, medications known as vasopressors may be administered to temporarily elevate blood pressure and improve cerebral blood flow, all while closely monitoring the patient’s neurological status. Diagnostic imaging, typically a CT scan or an MRI with diffusion-weighted imaging, is used to confirm the diagnosis and visualize the characteristic pattern of tissue damage in the border zones. This imaging helps to differentiate it from a stroke caused by a large vessel occlusion.

Following the acute phase, the patient begins a rehabilitation pathway tailored to the specific functional deficits resulting from the injury. Physical, occupational, and speech therapists work with the patient to maximize recovery of motor function, coordination, and cognitive abilities. Long-term management involves control of vascular risk factors, such as high blood pressure and cholesterol, and often includes antiplatelet medications to prevent future ischemic events.